PATRICIA BAGINSKI: Open Payments
NPI 1801052279 · GLASTONBURY, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$398 in 12 payments from 4 companies in 2025. Trend: 2023 $0 · 2024 $298 · 2025 $398
Food & beverage: $398
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $201 |
| ABBVIE INC. | 5 | $165 |
| Teva Pharmaceuticals USA, Inc. | 1 | $17 |
| Otsuka America Pharmaceutical, Inc. | 1 | $16 |
Products named: CAPLYTA, VRAYLAR, UZEDY, REXULTI.
Industry payments across CT — which companies pay providers there.
